Engaging Patients to Help Achieve Increased Patient Choice and Engagement for AFib Stroke Prevention
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Paul J Wang, MD
Stanford University
Principal Investigator - Randall S Stafford, MD
Stanford University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Stanford University
Palo Alto, California, United States
- Ochsner Medical Center
New Orleans, Louisiana, United States
- Cooper University Hospital
Camden, New Jersey, United States
- East Carolina University
Greenville, North Carolina, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Dec 2019
- Primary completion
- 23 Jun 2022
- Completion
- 17 Aug 2022
- Last update posted
- 5 Apr 2024
- Registered enrollment
- 1,001
- Registry id
- NCT04096781
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.